国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
20期
2536-2538
,共3页
章金灿%郑大明%许贤彬%陆卫歆%杨燕珠%苏锦霞
章金燦%鄭大明%許賢彬%陸衛歆%楊燕珠%囌錦霞
장금찬%정대명%허현빈%륙위흠%양연주%소금하
胃肠出血%阿司匹林%血红蛋白%转铁蛋白%胃镜检查
胃腸齣血%阿司匹林%血紅蛋白%轉鐵蛋白%胃鏡檢查
위장출혈%아사필림%혈홍단백%전철단백%위경검사
Gastrointestinal hemorrhage%Aspirin%Hemoglobin%Transferrin%Gastroscopy
目的 探讨粪便隐血免疫双联法在监测服用小剂量肠溶阿司匹林(ASA)致消化道出血中的应用价值.方法 对328例需长期服用小剂量ASA的患者和对照组30例,要求不服用口服抗凝剂、无消化道出血征象的心脑血管疾病患者,分别于服药前、服用1周、1个月、3个月、6个月应用隐血免疫双联法(血红蛋白免疫法和转铁蛋白免疫法)检测粪便隐血,阳性者再行胃镜检查,确定上消化道出血与否.结果 ①治疗组328例检出粪便隐血免疫双联法阳性40例,阳性率(12.2%),与对照组(3.3%)比较,差异有显著性(P<0.05);②治疗组粪便隐血免疫双联法阳性40例中行胃镜检查29例,示病理意义24例,另外5例的粪便隐血血红蛋白免疫法及转铁蛋白免疫法却都阳性;③治疗组粪便隐血免疫双联法阳性40例的出血监测时间差异无显著性(P>0.05).结论 可以常规应用粪便隐血免疫双联法监测长期服用小剂量ASA引起的消化道出血.
目的 探討糞便隱血免疫雙聯法在鑑測服用小劑量腸溶阿司匹林(ASA)緻消化道齣血中的應用價值.方法 對328例需長期服用小劑量ASA的患者和對照組30例,要求不服用口服抗凝劑、無消化道齣血徵象的心腦血管疾病患者,分彆于服藥前、服用1週、1箇月、3箇月、6箇月應用隱血免疫雙聯法(血紅蛋白免疫法和轉鐵蛋白免疫法)檢測糞便隱血,暘性者再行胃鏡檢查,確定上消化道齣血與否.結果 ①治療組328例檢齣糞便隱血免疫雙聯法暘性40例,暘性率(12.2%),與對照組(3.3%)比較,差異有顯著性(P<0.05);②治療組糞便隱血免疫雙聯法暘性40例中行胃鏡檢查29例,示病理意義24例,另外5例的糞便隱血血紅蛋白免疫法及轉鐵蛋白免疫法卻都暘性;③治療組糞便隱血免疫雙聯法暘性40例的齣血鑑測時間差異無顯著性(P>0.05).結論 可以常規應用糞便隱血免疫雙聯法鑑測長期服用小劑量ASA引起的消化道齣血.
목적 탐토분편은혈면역쌍련법재감측복용소제량장용아사필림(ASA)치소화도출혈중적응용개치.방법 대328례수장기복용소제량ASA적환자화대조조30례,요구불복용구복항응제、무소화도출혈정상적심뇌혈관질병환자,분별우복약전、복용1주、1개월、3개월、6개월응용은혈면역쌍련법(혈홍단백면역법화전철단백면역법)검측분편은혈,양성자재행위경검사,학정상소화도출혈여부.결과 ①치료조328례검출분편은혈면역쌍련법양성40례,양성솔(12.2%),여대조조(3.3%)비교,차이유현저성(P<0.05);②치료조분편은혈면역쌍련법양성40례중행위경검사29례,시병리의의24례,령외5례적분편은혈혈홍단백면역법급전철단백면역법각도양성;③치료조분편은혈면역쌍련법양성40례적출혈감측시간차이무현저성(P>0.05).결론 가이상규응용분편은혈면역쌍련법감측장기복용소제량ASA인기적소화도출혈.
Objective To explore the application value of dejecta occult blood coupled with hemoglobin and/or transferrin monoclonal immunoassay on inspect gastrointestinal bleeding induced by taking low-dose ASA.Methods 328 cases taking low-dose ASA in long-time were set as therapy group;30 cases patients with Heart-Brain vas disease not taking ASA and not having the sign of gastrointestinal bleeding were set as control group,Detected dejecta occult blood with hemoglobin and/or transferrin monoclonal immunoassay 1 week,1 month,3 months,6 months before taking medicine.Took Gastroscopy if dejecta occult blood were positive to see if upper gastrointestinal were bleeding or not.Results ① Among these 328 patients,dejecta occult blood was detected with hemoglobin and/or transferrin monoclonal immunoassay; 40 cases were positive( 12.2% )in therapy group,while control group had 1 case(3.3%,1/30);there was statistical difference ( P < 0.05 ).② There were 29 cases taking Gastroscopy of 40 cases whose dejecta occult blood was positive; 24 cases had pathology significance; hemoglobin and transferrin monoclonal immunoassay was positive of the other 5 cases.③There was no statistical significant difference on bleeding time (P> 0.05 ).Conclusion Dejecta occult blood detected with hemoglobin and/or transferrin monoclonal immunoassay could be a routine inspection for gastrointestinal bleeding induced by taking low-dose ASA in long-time.